Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. AbbVie Inc (ABBV)
  7. Financials

ABBV

AbbVie Inc
155.13
-0.99 (-0.63%)
Upgrade to Real-Time

AbbVie Inc. (ABBV) Fundamentals
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
SHARE INFORMATION
Market Cap$ 276,238,723,473
Shares Outstanding1,769,399,971
Float1,767,899,492
Percent Float99.92%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 5.64
Latest Fiscal Revenue$ 58,054,000,000
Latest Fiscal EPS$ 6.63
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)$ 17.28
Dividend (5 Years)$ 19.63
Ex Dividend Date2023-04-13
Dividend Rate$ 5.92
Dividend Yield3.79%
Payment CashCash
HOLDERS
Institutions4,639
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months62,081,939
Institutional Holdings Percent125.4%
Institutional Sold Previous 3 Months69,972,135
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months1,228,854
Insider Holdings Percent0.2
Insider Sold Previous 3 Months232,830
Insider Shares Owned2,988,462
TRADING INFO
52 Week High$ 175.91
52 Week Low$ 134.09
52 Week High Change$ 1.80
21 Day Moving Average$ 153.001
21 Day Extended Moving Average$ 152.8742
50 Day Moving Average$ 151.3659
50 Day Extended Moving Average$ 152.7263
200 Day Moving Average$ 147.2409
200 Day Extended Moving Average$ 149.3836
10 Day Average Volume9,672,958
20 Day Average Volume7,809,838
30 Day Average Volume7,234,846
50 Day Average Volume6,838,330
Alpha0.007134
Beta0.6150
Standard Deviation0.081836
R20.163759
7 Day Price Change$ 4.17
7 Day Percent Change2.74%
21 Day Price Change$ 1.84
21 Day Percent Change1.19%
30 Day Price Change$ 4.81
30 Day Percent Change3.18%
Month to Date Price Change$ 2.22
Month to Date Percent Change1.44%
Quarter to Date Price Change$ -3.97
Quarter to Date Percent Change-2.48%
180 Day Price Change$ 17.10
180 Day Percent Change12.3%
200 Day Price Change$ 20.36
200 Day Percent Change14.99%
Year to Date Price Change$ -3.97
Year to Date Percent Change-2.48%

AbbVie Inc. (ABBV) Key Ratios

PROFITABILITY
EBIT Margin29.4%
EBITDA Margin43.8%
Pre-Tax Profit Margin16.4%
Profit Margin Count20.27%
Gross Margin70.0%
Profit Margin TOT20.27%
INCOME STATEMENTS
Revenue$ 58,054,000,000
Revenue Per Share$ 32.81
Revenue (3 Years)$ 20.62
Revenue (5 Years)$ 17.17
FINANCIAL STRENGTH
Price to Tangible Book-3.30
Total Debt To Equity3.70
Int Coverage7.00
Current Ratio1.00
Leverage Ratio8.80
Quick Ratio0.70
Long Term Debt To Capital0.77
VALUATION MEASURES
PE Ratio23.30
Enterprise Value$ 326,918,863,527
Price to Sales4.7583
Price to Free Cash20.30
PE High Last 5 Years781.90
Price To Book15.80
Price To Cash Flow11.00
PE Low Last 5 Years189.90
Price to Tangible Book-3.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover5.40
Invoice Turnover5.30
Assets Turnover0.40
Return Assets8.51
Return on Equity74.13
Return on Capital17.00

AbbVie Inc. (ABBV) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEORichard A. Gonzalez
Emplyoees50000
Last AuditUQ
CIK0001551152
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address1 North Waukegan Road
North Chicago, IL 60064-6400
Websitehttps://www.abbvieinvestor.com
Facsimile-
Telephone+1 847 932-7900
Emailliz.shea@abbvie.com


Your Recent History
NYSE
ABBV
AbbVie
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.